Vectura Share Discussion Threads

[bobo18] 21/4/2021 07:14

Win double - Advair and special divi!!

[volvo] 21/4/2021 07:10

Off to the races

[justiceforthemany] 20/4/2021 16:08

Hikma flat, Vec down 5%
Ridiculous

[a1ord53] 20/4/2021 07:35

Good morning ,as of now no electronic petition filing at Supreme Court US by GSK.
Expecting news from Vectura concerning date of divi payment.
Polaris and GBcol thanks for updates.

PS vec 5% down for the day - very disappointing !
Market makers always shorting Vectura regardless .Its a shame to work with these b ...ds !
Management also issuing themselves millions of shares without any merits yet( GSK,Advair , ..merits of previous mgmt ).

Management doesn’t do any marketing for the company and releasing news late and poorly !


Looks like they don’t want keep momentum and trend. Why ?

So for now GSK settlement is final, Advair will finally totally approved by June , divi coming soon, Paciras payment within 1 year, Ellipta development going on, CDMO progressing and busonide Astma treatment for COVID will also cleared ..... what Else ? Two partnerships under way with targeting also China ...

[gbcol] 19/4/2021 11:23

GBCol Apr '21 - 10:45 - 11378 of 11386

I’ll try to send something over to them later.

Edit: emailed IR earlier, will post here if I get a reply.


I got a brief reply from IR confirming that VEC are involved with potential effectiveness of certain inhalers to treat COVID-19. 2 of the CDMO projects relate to COVID-19 treatment (feasibility stage). I asked about budesonide but this wasn’t specifically answered.

[polaris] 17/4/2021 11:09

Pacira back up to Exparel run-rate to meet the $500 M milestone on a 12-month basis in March 2021 ($44.3 M). Qly sales came in at $114.7 M, just below necessary run-rate.

Pacira announced an additional indication approval for pediatric patients in late March and will launch Exparel in the EU in H2 2021. Expect monthly sales to rise as other delayed elective procedures restart in the US. HY is now key for payment in FY2021 for VEC.

On the downside, Pacira filed a lawsuit against one of the US medical journals for misrepresentation of the effectiveness of Exparel:

[boadicea] 16/4/2021 16:35

A big sell 10 minutes before close on a Friday. Will there be more in the closing auction to make it look sick over the weekend?

[marvelman] 15/4/2021 10:20

Thats helpful info alord...many thanks

[jeevsje] 14/4/2021 08:26

Order book looks weird on both buy and sell sides.

[redips2] 14/4/2021 08:13

......and so have I.

[jeevsje] 13/4/2021 18:15

Two holders reducing

[lsoc85] 13/4/2021 15:28

Good man 👍

[gbcol] 13/4/2021 10:45

I’ll try to send something over to them later.

Edit: emailed IR earlier, will post here if I get a reply.

[lsoc85] 13/4/2021 10:44

GPs are going to be dishing this stuff out left, right and centre.

[lsoc85] 13/4/2021 10:16

Don't look at me. The last time I tried something proactive for the long term investor, I was branded a comic entertainer's footwear.

[rogerrail] 13/4/2021 08:05

Vectura clickhaler had marketing approval through Mylan (2008) but it appears the product was not launched."Regulatory approvals have also been received for Clickhaler® budesonide in Germany, the Netherlands and New Zealand"

[lsoc85] 13/4/2021 07:51

VR475 was known as Favolir when Vec ran with it following the acquisition of Activaero in 2014. This would suggest VR475 was a different formula to budesonide which has been around for decades. Hopefully, Vec still do a line in conventional budesonide that can be scaled up sharpish to meet the inevitable demand.

[fhmktg] 13/4/2021 07:32

VR475 was abandoned with a £40 million write off!

[fhmktg] 13/4/2021 07:28

Do VEC have any market advantage in delivery technology to enhance the drug ?

[lsoc85] 13/4/2021 06:30

BBC News - Covid: Asthma drug 'speeds up recovery at home'


Hopefully Vec will be at the forefront of global supply of the inhaled budesonide. Demand will likely rocket, especially in Europe given their dreadful vaccine rollout.

[jimboyce] 12/4/2021 16:46

Rinse and repeat......